[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)] [Notices] [Pages 19787-19788] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 98-10546] ----------------------------------------------------------------------- DEPARTMENT OF VETERANS AFFAIRS Research and Development Cooperative Studies Evaluation Committee; Notice of Meeting The Department of Veterans Affairs gives notice under Public Law 92-463 (Federal Advisory Committee Act) as amended, by section 5(c) of Public Law 94-409, that a meeting of the Research and Development Cooperative Studies Evaluation Committee will be held at the Marriott Residence Inn, 500 Army Navy Drive, Arlington, VA 22202, on May 4-5, 1998. The session on May 4 is scheduled to begin at 7:30 a.m. and end at 5:30 p.m. and on May 5 from 7:30 a.m. to 5:15 p.m. The meeting will be for the purpose of reviewing the following seven new proposals: therapy for hepatitis C related cirrhosis, prophylaxis of medical patients for thromboembolism, telemedicine on diabetic retinopathy, iron and atheroclerosis, influenza vaccine for COPD patients, therapy for heart failure patients, and hernia repair. The Committee will also review the progress of one ongoing study of treatment for liver fibrosis. The Committee advises the Chief Research and Development Officer through the Chief of the Cooperative Studies Program on the relevance and feasibility of the studies, the adequacy of the protocols, and the scientific validity and propriety of technical details, including protection of human subjects. The meeting will be open to the public from 7:30 a.m. to 8:00 a.m. on both days to discuss the general status of the program. Those who plan to attend should contact Dr. Ping Huang, Coordinator, Research and Development Cooperative Studies Evaluation Committee, Department of Veterans Affairs, 810 Vermont Avenue, NW, Washington, DC, (202-273- 8295), prior to April 30, 1998. [[Page 19788]] The meeting will be closed from 8:00 a.m. to 5:30 p.m. on May 4, 1998, and from 8:00 a.m. to 5:15 p.m., on May 5, 1998. These portions of the meeting involve consideration of specific proposals in accordance with provisions set forth in section 10(d) of Public Law 92- 463, as amended by section 5(c) of Public Law 92-409, and 5 U.S.C. 552b(c)(6). During the closed sessions of the meeting, discussions and recommendations will deal with qualifications of personnel conducting the studies, staff and consultant critiques of research protocols, and similar documents, and the medical records of patients who are study subjects, the disclosures of which would constitute a clearly unwarranted invasion of personal privacy. Dated: April 14, 1998. By Direction of the Acting Secretary. Heyward Bannister, Committee Management Officer. [FR Doc. 98-10546 Filed 4-20-98; 8:45 am] BILLING CODE 8320-01-M
Document
Research and Development Cooperative Studies Evaluation Committee; Notice of Meeting
[Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)] [Notices] [Pages 19787-19788] From the Federal Register Online via the Government Publishing Office [ www.gpo.g...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
63 FR 19787
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Research and Development Cooperative Studies Evaluation Committee; Notice of Meeting,” thefederalregister.org (April 21, 1998), https://thefederalregister.org/documents/98-10546/research-and-development-cooperative-studies-evaluation-committee-notice-of-meeting.